CD86 and Increased total eosinophil count: Asai-Tajiri and colleagues managed to experimentally attenuate allergic inflammation, including eosinophilia, IgE and TH2 cytokine expression in lung upon OVA-exposure, by blocking CD86 locally with siRNA [33].